NEOM, an ambitious vision of the future where innovative solutions converge with sustainable living, has just reached a monumental milestone by raising $5 billion in funding. This impressive capital boost is set to fuel NEOM’s bold mission of redefining how we live, work, and interact with our environment. With this infusion of financial strength, NEOM is positioned to further develop its transformative projects that blend cutting-edge technology with enduring principles of environmental stewardship. The company envisions a destination that not only serves as a home for forward-thinking individuals but also stands as a beacon of progress for communities worldwide. By integrating advanced renewable energy systems, smart infrastructure, and eco-friendly urban planning, NEOM is building the foundation for a future where sustainability meets modernity. This latest funding round will drive significant investments in critical infrastructure, research and development, and strategic partnerships, enabling the creation of innovative solutions that address global challenges. As we embark on this exciting journey, NEOM intends to accelerate projects that merge digital innovation with real-world applications, ultimately fostering economic growth and improved quality of life. Backed by visionary investors who share the belief in a reimagined way of living, NEOM is set to become much more than a destination—it will be a dynamic ecosystem that nurtures creativity, collaboration, and resilience. The infusion of $5 billion empowers NEOM to build a new sustainable model that inspires the world, attracts talent, and leads a global transformation towards a smarter, greener, and more connected future.

NEOM Secures $5 Billion Funding to Build a New Model for Sustainable Living
Get the full Neom company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Raptor Scientific
Leading Technology for Mission Critical Applications Raptor Scientific offers an extensive range of test and measurement capabilities, including Mass Properties, Radar Cross Section Measurement Instruments, Air Data Test Systems, Pressure, Temperature, Torque & Force Measurement Instruments, Igniter Circuit Testers, Heat Flux Sensors, Infrared Radiometers, and Thermocouples for developers of high-performance systems for whom failure is not an option. Our groundbreaking solutions offer the highest level of accuracy, safety, and exceptional product reliability.
$100.0K Unknown
today

Quantifly
Quantifly (TM) changes how parking and traffic studies are done. No more weeks of planning, RFPs, and hiring interns. Just select the type, duration, and location of your study, if you need a drone pilot or need us to provide one, then we do the rest. In about a week you get the photos, video, and car count data created automatically with our proprietary algorithm, and requested reports. No more counting cars in the snow. Parking and traffic counts are essential to urban development. Without them municipalities and developers have few options to calculate parking or street capacity. These studies are costly, time consuming, and consist of people manually counting cars on foot in all seasons using pen and paper, increasing the possibility for human error. The analog data from these studies are transcribed to a proprietary database and often left siloed. We save our clients time and money, minimize human error, and use visual data to increase the quality of communication with elected officials and the general public. As we get more data, we give planners and developers tools to dictate how and where parking happens. Quantifly is a joint venture wholly owned and operated by Autonomous Scientific and Pivot Planning & Design.
$600.0K Seed
today

Pulmonx Corporation
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1 1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.
$66.0M Series d
today

Penteo Audio Plugins
Since 2012, Penteo’s unique phaseless AAX / VST3 / AU audio plugins produce the highest quality multichannel upmix/downmix that always adheres to the original mixers intent: nothing is artificially added, altered or removed from the source in Penteo's upmix / downmix process. Free 14-day trial: www.perfectsurround.com/freetrial
$100.0K Unknown
today

Oculyze
Using machine learning and Artificial Intelligence Oculyze has transferred the computer vision software for lab equipment from the table top to the cloud. To prove this revolutionary approach works and is market ready, Oculyze launched the yeast cell counters for breweries and wineries. This device works using a microscope connected to a smartphone and the Oculyze app to upload the images to the cloud where they are analysed by image recognition algorithms. These combine methodical pattern recognition with artificial intelligence and deep learning to offer quantitative real-time image analysis. The cell counter has convinced yeast labs, breweries and wineries of all sizes around the world (Oculyze Better Brewing + Fermentation Wine). Oculyze MUH is the third turnkey product and allows for an on-site diagnosis of subclinical endometritis for cows. The next step for Oculyze is to use this proven technology to bring the advantages of cloud based image recognition, like faster development time, lower cost and better image recognition, to other applications like blood or sperm counts, parasite detection in feces, asbestos fibre detection, emulsion analysis and bacteria detection, hereby continuing to add applications to its cloud based image recognition platform. The beauty of this solution is that it can be delivered in two ways: One is a brand new system developed specifically for an application, and the second is the combination of APIs and Apps that enable the company to upgrade existing hardware like scanning electron microscopes (SEM) or the good old lab microscope.
$100.0K Seed
today